These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10389214)

  • 1. Genetic prediction of coronary heart disease: lessons from Canada.
    Hegele RA
    Scand J Clin Lab Invest Suppl; 1999; 230():153-67. PubMed ID: 10389214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of genetic profiling for the prediction of coronary heart disease.
    van der Net JB; Janssens AC; Sijbrands EJ; Steyerberg EW
    Am Heart J; 2009 Jul; 158(1):105-10. PubMed ID: 19540399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparity between association and linkage analysis for HNF1A G319S in type 2 diabetes in Canadian Oji-Cree.
    Hegele RA; Hanley AJ; Zinman B; Harris SB; Anderson CM
    J Hum Genet; 2000; 45(3):184-7. PubMed ID: 10807546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study.
    Pearte CA; Furberg CD; O'Meara ES; Psaty BM; Kuller L; Powe NR; Manolio T
    Circulation; 2006 May; 113(18):2177-85. PubMed ID: 16651468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of genetic polymorphisms and conventional risk factors to predict coronary heart disease in patients with familial hypercholesterolemia.
    van der Net JB; Janssens AC; Defesche JC; Kastelein JJ; Sijbrands EJ; Steyerberg EW
    Am J Cardiol; 2009 Feb; 103(3):375-80. PubMed ID: 19166692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of first events of coronary heart disease and stroke with consideration of adiposity.
    Wilson PW; Bozeman SR; Burton TM; Hoaglin DC; Ben-Joseph R; Pashos CL
    Circulation; 2008 Jul; 118(2):124-30. PubMed ID: 18591432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of multiple cardiac risk factors in US adults with diabetes.
    McCollum M; Ellis SL; Morrato EH; Sullivan PW
    Curr Med Res Opin; 2006 Jun; 22(6):1031-4. PubMed ID: 16846537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyslipidaemia and coronary heart disease: nature vs nurture.
    Hegele RA
    Br J Hosp Med; 1995 Aug 16-Sep 5; 54(4):143-6. PubMed ID: 7582364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey.
    Ko M; Kim MT; Nam JJ
    Int J Cardiol; 2006 Jun; 110(2):184-90. PubMed ID: 16412525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.
    Lamarche B; Lemieux I; Després JP
    Diabetes Metab; 1999 Sep; 25(3):199-211. PubMed ID: 10499189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Mediterranean paradox for susceptibility factors in coronary heart disease extends to genetics.
    Lao O; Dupanloup I; Barbujani G; Bertranpetit J; Calafell F
    Ann Hum Genet; 2008 Jan; 72(Pt 1):48-56. PubMed ID: 17683517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of cardiovascular disease risk factors in patients from Croatian Zagorje County treated at Department of Medicine, Zabok General Hospital from 2000 to 2006.
    Pesek K; Pesek T; Rados M; Buković D; Fures R; Cuk V
    Coll Antropol; 2007 Sep; 31(3):709-15. PubMed ID: 18041378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population.
    Meisinger C; Baumert J; Khuseyinova N; Loewel H; Koenig W
    Circulation; 2005 Aug; 112(5):651-7. PubMed ID: 16043640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of coronary heart disease in a population with high prevalence of diabetes and albuminuria: the Strong Heart Study.
    Lee ET; Howard BV; Wang W; Welty TK; Galloway JM; Best LG; Fabsitz RR; Zhang Y; Yeh J; Devereux RB
    Circulation; 2006 Jun; 113(25):2897-905. PubMed ID: 16769914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to identify gene-environment interactions in a multifactorial disease: CHD as an example.
    Talmud PJ
    Proc Nutr Soc; 2004 Feb; 63(1):5-10. PubMed ID: 15070435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW
    Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The microsomal triglyceride transfer protein gene-493T variant lowers cholesterol but increases the risk of coronary heart disease.
    Ledmyr H; McMahon AD; Ehrenborg E; Nielsen LB; Neville M; Lithell H; MacFarlane PW; Packard CJ; Karpe F;
    Circulation; 2004 May; 109(19):2279-84. PubMed ID: 15136504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of meta-analysis risk estimates for candidate genes in combination to predict coronary heart disease risk.
    Drenos F; Whittaker JC; Humphries SE
    Ann Hum Genet; 2007 Sep; 71(Pt 5):611-9. PubMed ID: 17403027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.